23
Ashland
completes ISP acquisition
Ashland Inc. has completed its acquisition of privately owned International Specialty Products Inc. (ISP). “This defining transaction is expected to be immediately accretive and will significantly expand our position in higher- margin, higher-growth end markets, including personal care, pharmaceutical, food and beverage and energy,” said James J. O’Brien, Ashland Chairman and Chief Executive Officer. “We are excited about combining ISP’s technologies and capabilities with our own. This acquisition enhances our ability to satisfy the increasing global demand for more technologically advanced consumer and industrial products, and to continue to generate industry-leading innovation and solutions for our customers.”
ISP will be integrated into the Ashland Aqualon Functional Ingredients commercial unit, more than doubling the size of Ashland’s highest-margin business. Effective immediately, the combined unit will be called Ashland Specialty Ingredients. Going forward, Ashland Specialty Ingredients is expected to contribute roughly half of Ashland’s EBITDA. In addition, approximately half of Ashland’s overall revenues will now be derived outside of North America. An integration team with key
representatives of both companies is being led by John Panichella, President of the new Ashland Specialty Ingredients business. Ashland anticipates approximately $50 million in annual run- rate savings by the end of the second year through eliminating redundancies and capturing operational efficiencies. Panichella commented: “The addition of
ISP greatly expands the breadth of our technology platforms and provides new resources and capabilities to better capitalise on market opportunities. In particular, we now can offer our customers one of the broadest, most functional portfolios of water-soluble polymers in the world.” ISP, Stand D30
Ashland Specialty Ingredients, Stand C30
Perfect peptides
Mibelle Biochemistry is presenting PerfectionPeptide P3. An important process in aged skin is desquamation, which is the shedding of dead stratum corneum cells. Desquamation is part of the continuous renewal of the epidermis. PerfectionPeptide P3 is a tri-peptide that stimulates natural desquamation in aged skin where this process is reduced and inhomogeneous leading to a longer epidermal turnover time and to dry, scaly and uneven skin. PerfectionPeptide P3 provides a biomimetic peeling effect without disrupting the skin barrier causing irritations such as with chemical peels. PerfectionPeptide P3 provides the following benefits: • Rejuvenates the skin by improving desquamation • Smoothes and evens the skin • Improves the texture of sun-damaged skin Mibelle Biochemistry, Stand F58
An innovation for natural and ecofriendly make-up
As a substitute for mineral or chemical micronised powders, Lessonia is launching the Microzest 25 ST (Surface treated) range. Microzest 25 are plants and dried plant extracts micronised at 25 microns to be used as a pigment. Thanks to Lessonia's micronisation technology, the very fine powder obtained reveals intense colours. These plant pigments, technologically
transformed with a subtle association with natural esters and waxes, offer new possibilities for coloured cosmetics and make-up.
Lessonia is
presenting different formulas using the plant pigments: lip glosses, eye
shadows, bath salts, pressed powders and loose powders. The formulas will demonstrate the intense colours and silky touch obtained thanks to the surface treatment technology. Lessonia, Stand FP12
Visibly brighter skin in 2 weeks
DSM Nutritional Products Ltd. is presenting its unique product called REGU® REGU®
-FADE. -FADE evens
and brightens skin tone using pure, nature- identical resveratrol that addresses high consumer awareness about visible effects. Resveratrol is known as a potent antioxidant that is found in red grapes and is associated with various health benefits. DSM scientists showed that REGU®
-FADE
attenuates skin pigmentation via multiple mechanisms, from initial signalling and gene expression to melanin production and final melanosome transfer. The success of REGU®
-FADE leads to significant and
-FADE’s multi-target
approach was reflected in two clinical trials, both long term and short term, demonstrating that REGU®
visible skin brightening results. This strong scientific substantiation, coupled with DSM’s competence and quality approach means that REGU®
-FADE is not only effective, but also
fulfils the highest quality and purity standards and is safe for cosmetic applications. DSM Nutritional Products Ltd, Stand D20
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52 |
Page 53 |
Page 54 |
Page 55 |
Page 56 |
Page 57 |
Page 58 |
Page 59 |
Page 60 |
Page 61 |
Page 62 |
Page 63 |
Page 64 |
Page 65 |
Page 66 |
Page 67 |
Page 68 |
Page 69 |
Page 70 |
Page 71 |
Page 72 |
Page 73 |
Page 74 |
Page 75 |
Page 76 |
Page 77 |
Page 78 |
Page 79 |
Page 80 |
Page 81 |
Page 82 |
Page 83 |
Page 84 |
Page 85 |
Page 86 |
Page 87 |
Page 88 |
Page 89 |
Page 90 |
Page 91 |
Page 92 |
Page 93 |
Page 94 |
Page 95 |
Page 96 |
Page 97 |
Page 98 |
Page 99 |
Page 100 |
Page 101 |
Page 102 |
Page 103 |
Page 104